Gilead Sciences
GILD
#117
Rank
ยฃ120.37 B
Marketcap
ยฃ96.98
Share price
0.62%
Change (1 day)
25.55%
Change (1 year)

Market capitalization of Gilead Sciences (GILD)

Market cap: ยฃ120.37 Billion

As of May 2026 Gilead Sciences has a market cap of ยฃ120.37 Billion. This makes Gilead Sciences the world's 117th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Gilead Sciences from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ120.37 B4.77%
2025ยฃ114.89 B22.93%
2024ยฃ93.46 B17.96%
2023ยฃ79.23 B-10.98%
2022ยฃ89.00 B31.95%
2021ยฃ67.45 B25.9%
2020ยฃ53.57 B-14.6%
2019ยฃ62.73 B-0.69%
2018ยฃ63.17 B-8.77%
2017ยฃ69.24 B-9.44%
2016ยฃ76.45 B-21.26%
2015ยฃ97.09 B6.99%
2014ยฃ90.75 B29.91%
2013ยฃ69.85 B102.39%
2012ยฃ34.51 B74.51%
2011ยฃ19.78 B5.06%
2010ยฃ18.82 B-21.74%
2009ยฃ24.05 B-24.27%
2008ยฃ31.77 B47.68%
2007ยฃ21.51 B40.74%
2006ยฃ15.28 B9.07%
2005ยฃ14.01 B71.33%
2004ยฃ8.18 B17.74%
2003ยฃ6.94 B65.82%
2002ยฃ4.18 B-4.23%
2001ยฃ4.37 B66.99%
2000ยฃ2.61 B77.38%
1999ยฃ1.47 B94.76%
1998ยฃ0.75 B8.4%
1997ยฃ0.69 B66.63%
1996ยฃ0.41 B

End of Day market cap according to different sources

On May 1st, 2026 the market cap of Gilead Sciences was reported to be:

ยฃ120.39 Billion
by Nasdaq info icon info icon
ยฃ120.37 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ402.87 B 234.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ110.33 B-8.34%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ269.19 B 123.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ635.00 B 427.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ131.12 B 8.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ20.34 B-83.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ15.19 B-87.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ79.43 B-34.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ204.07 B 69.53%๐Ÿ‡บ๐Ÿ‡ธ USA